Balyasny Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Balyasny Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-771,620	Closed	-$142M	–	2304
2021 Q2	$142M	Sell	771,620 -28,724	-4%	-$5.28M	0.67%	10
2021 Q1	$122M	Buy	800,344 +470,542	+143%	+$72M	0.6%	11
2020 Q4	$51.5M	Buy	329,802 +13,774	+4%	+$2.15M	0.29%	62
2020 Q3	$36.2M	Buy	316,028 +169,506	+116%	+$19.4M	0.27%	69
2020 Q2	$16.4M	Buy	146,522 +50,303	+52%	+$5.65M	0.14%	191
2020 Q1	$8.64M	Sell	96,219 -220,280	-70%	-$19.8M	0.1%	249
2019 Q4	$34.2M	Buy	316,499 +314,169	+13,484%	+$34M	0.2%	139
2019 Q3	$228K	Sell	2,330 -43,347	-95%	-$4.24M	﹤0.01%	944
2019 Q2	$5.98M	Sell	45,677 -82,921	-64%	-$10.9M	0.04%	465
2019 Q1	$17.4M	Sell	128,598 -256,347	-67%	-$34.7M	0.12%	235
2018 Q4	$37.5M	Buy	384,945 +73,144	+23%	+$7.12M	0.27%	89
2018 Q3	$43.3M	Buy	311,801 +160,733	+106%	+$22.3M	0.2%	119
2018 Q2	$18.8M	Sell	151,068 -370,070	-71%	-$45.9M	0.09%	284
2018 Q1	$58.1M	Sell	521,138 -704,352	-57%	-$78.5M	0.24%	84
2017 Q4	$147M	Buy	1,225,490 +1,052,546	+609%	+$126M	0.46%	29
2017 Q3	$24.3M	Sell	172,944 -15,286	-8%	-$2.14M	0.1%	247
2017 Q2	$22.9M	Buy	188,230 +105,071	+126%	+$12.8M	0.09%	256
2017 Q1	$10.1M	Sell	83,159 -130,741	-61%	-$15.9M	0.05%	427
2016 Q4	$26.2M	Buy	213,900 +42,168	+25%	+$5.16M	0.14%	184
2016 Q3	$21M	Buy	171,732 +72,669	+73%	+$8.9M	0.12%	231
2016 Q2	$11.6M	Buy	99,063 +9,177	+10%	+$1.07M	0.07%	272
2016 Q1	$12.5M	Buy	89,886 +45,948	+105%	+$6.4M	0.07%	279
2015 Q4	$8.38M	Buy	+43,938	New	+$8.38M	0.06%	360
2015 Q3	–	Sell	-35,000	Closed	-$6.33M	–	1252
2015 Q2	$6.33M	Sell	35,000 -91,681	-72%	-$16.6M	0.04%	396
2015 Q1	$22M	Buy	+126,681	New	+$22M	0.18%	154
2014 Q3	–	Sell	-26,400	Closed	-$4.13M	–	673
2014 Q2	$4.13M	Buy	+26,400	New	+$4.13M	0.05%	300